The Middle East and North Africa (MENA) region is witnessing a significant rise in allergy diagnoses due to various environmental factors and increasing urbanization. Air pollution and allergens play a crucial role in exacerbating allergies, leading to a growing demand for accurate and early diagnostic solutions. The market for allergy diagnostics in MENA is driven by the need for effective prevention and curative therapies.
Access Full Report at https://www.databridgemarketresearch.com/reports/middle-east-and-north-africa-allergy-diagnostics-market
Data Bridge Market Research analyses that the Middle East and North Africa Allergy Diagnostics Market which is USD 276.32 billion in 2022, is expected to reach USD 558.72 billion by 2030, at a CAGR of 9.2% during the forecast period 2023 to 2030. The increasing adoption of telemedicine and remote testing solutions in the MENA region has driven the demand for allergy diagnostics. These remote options enhance accessibility, enabling patients in remote areas to access timely and accurate allergy evaluations, contributing to the market's growth
Key Findings of the Study
Rising patient awareness about the significance of early allergy diagnosis and effective management is expected to drive the market's growth rate
Rising patient awareness about the significance of early allergy diagnosis and effective management has fueled the demand for allergy testing services in the MENA region. As patients become more knowledgeable about allergies and their potential impact on health, they are actively seeking diagnostic solutions to identify allergens and receive appropriate treatment. This increased awareness has created a growing market for allergy diagnostics as healthcare providers strive to meet the demand for accurate and timely testing services to support effective allergy management.
Report Scope and Market Segmentation
|
Report Metric
|
Details
|
|
Forecast Period
|
2023 to 2030
|
|
Base Year
|
2022
|
|
Historic Years
|
2021 (Customizable to 2015-2020)
|
|
Quantitative Units
|
Revenue in USD Billion, Volumes in Units, Pricing in USD
|
|
Segments Covered
|
Products and Services (Assay Kits, Instruments, Consumables and Services), Allergen (Inhaled Allergens, Food Allergens, Antibiotics, Other Drugs and Chemicals Allergens, Occupational Allergens, Miscellaneous Plant Allergens, Contact Allergens And Others), Test (In-Vitro Test and In-Vivo Test), End User (Hospitals, Diagnostic Laboratories, Academic Research Laboratories and Others), Distribution Channel (Direct and Indirect)
|
|
Countries Covered
|
Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA)
|
|
Market Players Covered
|
Thermo Fisher Scientific Inc., (U.S.), Siemens Healthcare GmbH (Germany), Danaher (U.S.), Omega Diagnostics Group PLC (U.K.), BIOMÉRIEUX (France), Romer Labs Division Holding (Austria), EUROIMMUN Medizinische Labordiagnostika AG (Germany), HollisterStier Allergy (U.S.), NEOGEN Corporation (U.S.), Eurofins Scientific (Luxembourg), Minaris Medical America, Inc. (U.S.), Stallergenes Greer (U.K.), HOB Biotech Group Corp., Ltd. (China), HYCOR Biomedical (U.S.), R-Biopharm AG (Germany), AESKU GROUP GmbH (Germany), ACON Laboratories, Inc. (U.S.), Lincoln Diagnostics, Inc. (U.S.), Astra Biotech GmbH (Germany), and Erba Group (U.K.)
|
|
Data Points Covered in the Report
|
In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
|
Segment Analysis:
The allergy diagnostics market is segmented on the basis of products and services, allergan, test, end-user, and distribution channel.
- On the basis of products and services, the allergy diagnostics market is segmented into assay kits, instruments, consumables, and services.
- On the basis of allergen, the allergy diagnostics market is segmented into inhaled allergens, food allergens, antibiotics, other drugs and chemicals allergens, occupational allergens, miscellaneous plant allergens, contact allergens, and others.
- On the basis of test, the allergy diagnostics market is segmented into in-vitro test and in-vivo test.
- On the basis of end user, the allergy diagnostics market is segmented into hospitals, diagnostic laboratories, academic research laboratories, and others.
- On the basis of distribution channel, the allergy diagnostics market is segmented into direct and indirect.
Major Players
Data Bridge Market Research recognizes the following companies as the major Middle East and North Africa allergy diagnostics market players in Middle East and North Africa allergy diagnostics market are Thermo Fisher Scientific Inc., (U.S.), Siemens Healthcare GmbH (Germany), Danaher (U.S.), Omega Diagnostics Group PLC (U.K.), BIOMÉRIEUX (France), Romer Labs Division Holding (Austria), EUROIMMUN Medizinische Labordiagnostika AG (Germany), HollisterStier Allergy (U.S.),
Market Developments
- In 2021, Minaris Medical America, Inc. replaced Hitachi Chemical Diagnostics, Inc. to strengthen Hitachi's global position and expand its in-vitro diagnostics business. Both companies are under Showa Denko Materials Co., Ltd.
- In 2021, PerkinElmer Inc. agreed to acquire Immunodiagnostic Systems Holdings PLC to bolster its presence in the ImmunoDiagnostics (IDS) industry. IDS will become a part of EUROIMMUN Medizinische LABORDIAGNOSTIKA AG, known for offering allergy products and services.
- In 2020, NEOGEN Corporation launched Reveal 3-D for Gluten.
- In 2019, Romer Labs Division Holding GmbH inaugurated its APAC Solutions Centre in Singapore, providing advanced facilities for food allergen testing.
Regional Analysis
Geographically, the countries covered in the Middle East and North Africa allergy diagnostics market report are Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA).
As per Data Bridge Market Research analysis:
Saudi Arabia is the dominant region in Middle East and North Africa allergy diagnostics market during the forecast period 2023 - 2030
Saudi Arabia dominates the allergy diagnostics market due to its significant healthcare infrastructure and high demand for diagnostic services. On the other hand, the UAE leads in allergy diagnostics manufacturing and exports crucial components used in allergy diagnostic tests. This synergy between the two countries strengthens the MENA region's position in the allergy diagnostics market, as it allows for efficient production and distribution of diagnostic products to meet the increasing demand for allergy testing services.
For more detailed information about the Middle East and North Africa allergy diagnostics market report, click here – https://www.databridgemarketresearch.com/reports/middle-east-and-north-africa-allergy-diagnostics-market
